Medicare Enrolled
Dr. Jose Reyes, M.D.
Surgery · Hyannis, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reyes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reyes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reyes
Dr. Jose Reyes is a surgery specialist in Hyannis, MA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Reyes performed 11,294 Medicare services across 4,742 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reyes received a total of $22,558 from 54 pharmaceutical and/or device companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reyes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 0% volume in MA
$22,558 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,294
Medicare services
Top 0% in MA for surgery
4,742
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~664 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
4,447 | $34 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,630 | $97 | $428 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,249 | $64 | $225 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
911 | $8 | $100 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
343 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
343 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
342 | $34 | $100 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
308 | $4 | $15 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
246 | $23 | $300 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
215 | $188 | $650 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
154 | $120 | $550 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 148 | $134 | $768 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
117 | $22 | $150 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
98 | $44 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $64 | $175 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
66 | $28 | $100 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
64 | $20 | $150 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
63 | $72 | $400 |
| Simple change of bladder tube | 57 | $71 | $350 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
50 | $46 | $155 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $139 | $600 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
38 | $97 | $2,858 |
| Insertion of temporary bladder tube | 37 | $35 | $147 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
32 | $257 | $800 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $11 | $50 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $329 | $1,591 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $108 | $589 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
19 | $2 | $15 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $93 | $280 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
18 | $30 | $150 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $188 | $900 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $48 | $462 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
16 | $141 | $500 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
15 | $34 | $75 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
13 | $219 | $584 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
12 | $59 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
12.4% medium
86.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,558
Total received (2018-2024)
Avg $3,223/year across 7 years
Top 9% in MA for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
228
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,744 (74.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,389 (23.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$425 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,782
2023
$5,841
2022
$1,225
2021
$4,851
2020
$4,153
2019
$828
2018
$877
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$3,611
Sumitomo Pharma America, Inc.
$223
Janssen Biotech, Inc.
$147
PROCEPT BioRobotics Corporation
$145
Ferring Pharmaceuticals Inc.
$126
Tolmar, Inc.
$103
ABBVIE INC.
$90
ACCORD HEALTHCARE, INC.
$79
Endo USA, Inc.
$74
C. R. Bard, Inc. & Subsidiaries
$47
UROGEN PHARMA, INC.
$43
Myriad Genetic Laboratories, Inc.
$40
PROGENICS PHARMACEUTICALS, INC.
$20
PFIZER INC.
$20
Calyxo, Inc.
$16
Top 3 companies account for 83.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$12,800
BOSTON SCIENTIFIC CORPORATION
$4,192
PROCEPT BioRobotics Corporation
$554
Janssen Biotech, Inc.
$469
Astellas Pharma US Inc
$305
Sumitomo Pharma America, Inc.
$292
PFIZER INC.
$287
ABBVIE INC.
$244
180 Medical, Inc.
$236
Ferring Pharmaceuticals Inc.
$210
AbbVie, Inc.
$199
Progenics Pharmaceuticals, Inc.
$194
UROGEN PHARMA, INC.
$187
UROVANT SCIENCES INC
$184
Tolmar, Inc.
$178
Agiliti Surgical, Inc.
$133
Intuitive Surgical, Inc.
$126
AbbVie Inc.
$125
Coloplast Corp
$120
W. L. Gore & Associates, Inc.
$102
Laborie Medical Technologies Corp.
$101
Augmenix, Inc.
$100
Antares Pharma, Inc.
$98
Myriad Genetic Laboratories, Inc.
$94
ACCORD HEALTHCARE, INC.
$79
Endo USA, Inc.
$74
Myovant Sciences Inc.
$63
Teleflex LLC
$61
Endo Pharmaceuticals Inc.
$61
Acerus Pharmaceuticals Corporation
$58
NeoTract Inc.
$55
C. R. Bard, Inc. & Subsidiaries
$47
TOLMAR Pharmaceuticals, Inc.
$40
Innovation Technologies Inc
$36
Avadel Specialty Pharmaceuticals, LLC
$36
Medtronic USA, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
KARL STORZ Endoscopy-America
$32
Dendreon Pharmaceuticals LLC
$31
Allergan Inc.
$30
Supernus Pharmaceuticals, Inc.
$25
ConvaTec Inc.
$25
Allergan, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$20
Foundation Medicine, Inc.
$20
Sun Pharmaceutical Industries Inc.
$20
Janssen Scientific Affairs, LLC
$19
Telix Pharmaceuticals
$18
Calyxo, Inc.
$16
COLOPLAST CORP
$15
Axonics, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Merck Sharp & Dohme Corporation
$14
Olympus America Inc.
$13
Top 3 companies account for 77.8% of all-time payments
Associated products mentioned in payments ›
24/26 FR. · ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · BIPOLAR · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CUTTING LOOP · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ELIGARD · ERLEADA · EXCLUDER AAA Endoprosthesis · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · GentleCath · ILLUCCIX · INTERSTIM · Irrisept · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Moses 550 D\F\L · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · Olympus Cystoscopes · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SOLTIVE · SOLYX · SPEEDICATH · Sonablate · SpaceOAR · SpeediCath · TLANDO · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · YONSA · ZYTIGA · bk3000 · bk3500 & bk5000 Ultrasound System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for surgery in MA.
Geographic Context
Surgerists within 10 mi
43
Per 100K population
18.7
County median income
$94,452
Nearest hospital
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reyes is a clinical cardiology specialist, with above-average Medicare volume (top 0% in MA), with consulting-driven industry engagement in the top 9% of MA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reyes experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Reyes performed 4,447 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reyes receive payments from pharmaceutical companies?
Yes. Dr. Reyes received a total of $22,558 from 54 companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reyes's costs compare to other surgerists in Hyannis?
Dr. Reyes's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reyes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Hyannis
Browse surgerists in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in MA
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in MA
Which MA surgerists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology